In this study, we used in vitro longitudinal live cell imaging, clonogenic assays, flow cytometry, immunofluorescence, in vivo hypoxia imaging and longitudinal tumor monitoring to elucidate the impact of dual HER2 and EGFR inhibition on cellular and molecular mechanisms of radiosensitivity. Here, ERBB2 is linked to neoplasm.